Strategic demand scenarios

in page functions

Long-term strategic demand scenarios offer visibility into future market needs to Gavi stakeholders including donors and industry partners.

Credit: Pfizer/2016.

Gavi, the Vaccine Alliance, uses strategic demand scenarios (SDSs) to improve its understanding of vaccine markets. In the context of the Gavi supply and procurement strategy, the SDS is an important tool to ensure clarity and understanding of the Gavi market for important stakeholders, including manufacturers and countries.

The SDSs produced by the Gavi Secretariat include all 73 countries that were eligible for Gavi support as of 2011 and a time horizon of 3 to 20 years.

Gavi benefits from the expertise of a Strategic Demand Advisory Team composed of Vaccine Alliance partners and other experts. This group provides advice to the Gavi Secretariat on the SDF including consultative support and technical endorsement of the vaccine specific SDSs.

Other consultations take place with vaccine experts in the public and private sectors to ensure the SDSs reflect the most important scenarios reflective of the evolution of each specific vaccine market. Gavi produces SDSs for 11 vaccines, including:

Related downloads

  • human papillomavirus
  • inactivated polio
  • Japanese encephalitis
  • measles-containing
  • meningococcal
  • pentavalent
  • pneumococcal conjugate
  • rotavirus
  • typhoid conjugate
  • yellow fever
  • cholera.

For more information regarding the Gavi Secretariat’s SDSs please contact forecast@gavi.org.

41 million

Since 2007, countries have immunised 41 million children with a second dose of measles or measles-rubella vaccine with Gavi support. Gavi-funded campaigns with these two vaccines have helped vaccinate another 328 million children in countries at high risk of outbreaks.

WHO/UNICEF and Gavi, 2017

More facts...

close icon

modal window here